82
late breaking Poster SESSIONS
LP-02-008
Multivoxel pattern analyses of brain struc-
ture to identify mild cognitive impairment
in Alzheimer‘s disease and Parkinson‘s dis-
ease: A pilot study
Ming-Ching Wen, Singapore, Singapore
W. L. Au, L. C. S. Tan, J. Zhou, N. Kandiah
LP-02-009
Cariprazine as adjunctive therapy in major
depressive disorder: A double-blind, pla-
cebo-controlled study
Willie Earley, Jersey City, USA
V. Mergel, S. Durgam, G. Németh, I. Laszlovszky
LP-02-010
Changes in mood-congruent attentional bi-
ases to dysphoric images moderate antide-
pressant response to duloxetine
Peter Giacobbe, Toronto, Canada
L. Grupp, U. Rakita, A. Fertman, M. Eizenman
LP-02-011
Empathic accuracy in individuals at familial
risk for depression: No effects of acute tryp-
tophan depletion
Koen Hogenelst, Groningen, Netherlands
R. Schoevers, M. Aan het Rot
LP-02-012
Social behavior and mood in individuals at
familial risk for depression: Investigating
the role of serotonin
Koen Hogenelst, Groningen, Netherlands
R. Schoevers, M. Aan het Rot
LP-02-014
A double-blind, randomized, placebo-con-
trolled, parallel group, dose frequency study
of intravenous ketamine in patients with
treatment-resistant depression
Jaskaran Singh, San Diego, USA
W. Drevets, H. Manji
LP-02-015
Efficacy and safety of intravenous esket-
amine in patients with treatment-resistant
depression: A double-blind, double-random-
ization, placebo-controlled phase 2a study
Jaskaran Singh, San Diego, USA
W. Drevets, H. Manji
LP-02-016
Efficacy of vortioxetine on cognitive function
in adult patients with major depressive dis-
order: Results of a randomized, double-blind,
active-referenced, placebo-controlled trial
Atul Mahableshwarkar, Deerfield, USA
J. Zajecka, W. Jacobson, Y. Chen, R. S. E. Keefe
wednesday, 25 June 2014
LP-03
LATE BREAKING
POSTER SESSION
17:15 - 18:45
Hall B
Miscellaneous
LP-03-001
Co-morbid medical conditions in vascular
dementia: A case-control study
Ruby Castilla-Puentes, Philadelphia, USA
M. Habeych
LP-03-002
The normalizing effect of the lythium salt of
cystein at Parkinson‘s syndrome
Gayane Ghazaryan, Yerevan, Armenia
L. Hovsepyan, H. Zanginyan
LP-03-004
Role of P2X7 ion channel in mood disorders:
Characterization of a P2X7 antagonist JNJ-
42253432 in the rat brain
Anindya Bhattacharya, San Diego, USA
L. Aluisio, J. Shoblock, B. Lord, P. de Haes,
W. Drinkenburg, A. Bouwknecht, M. Ceusters,
P. Bonaventure, M. Letavic, T. Lovenberg
LP-03-005
Brainstem evoked response audiometry bio-
markers in patients with schizophrenia and
adult ADHD
Tommy Lewander, Uppsala, Sweden
E. Baghdassarian, J. Källstrand, S. Nielzén
LP-03-006
Distinct role of melatonin MT1 and MT2 re-
ceptors in sleep neurophysiology: Insights
from MT1 and MT2 knockout mice and se-
lective compounds
Stefano Comai, Montreal, Canada
R. Ochoa-Sanchez, G. Gobbi
LP-03-007
Wake-promoting effects of BLK-030 and
BLK-032 versus modafinil in wild-type
C57BL/6J mice
Eric Konofal, Paris, France
G. Luca, Y. Emmenegger, L. Ferrié, B. Figadère,
M. Tafti, M. Lecendreux
